COL5A1 Serves as a Biomarker of Tumor Progression and Poor Prognosis and May Be a Potential Therapeutic Target in Gliomas

Glioma is the most common malignancy of the central nervous system. Although advances in surgical resection, adjuvant radiotherapy, and chemotherapy have been achieved in the last decades, the prognosis of gliomas is still dismal. COL5A1 is one of the collagen members with minor content but prominen...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Sujie, Peng, Zesheng, Wu, Yuxi, Wang, Yihao, Lei, Deqiang, Jiang, Xiaobing, Zhao, Hongyang, Fu, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635112/
https://www.ncbi.nlm.nih.gov/pubmed/34868960
http://dx.doi.org/10.3389/fonc.2021.752694

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635112/
https://www.ncbi.nlm.nih.gov/pubmed/34868960
http://dx.doi.org/10.3389/fonc.2021.752694

Ejemplares similares